Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial | Zendy

Salvatore Micali | Zendy; Angelo Territo | Zendy; Giacomo Maria Pirola | Zendy; Nancy Ferrari | Zendy; Maria Chiara Sighinolfi | Zendy; Eugenio Martorana | Zendy; Michele Navarra | Zendy; Giampaolo Bianchi | Zendy

Open Access

Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial

Author(s) -

Salvatore Micali,

Angelo Territo,

Giacomo Maria Pirola,

Nancy Ferrari,

Maria Chiara Sighinolfi,

Eugenio Martorana,

Michele Navarra,

Giampaolo Bianchi

Publication year - 2017

Publication title -

archivio italiano di urologia e andrologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.429

H-Index - 23

eISSN - 2282-4197

pISSN - 1124-3562

DOI - 10.4081/aiua.2017.3.197

Subject(s) - medicine , green tea extract , placebo , clinical trial , intraepithelial neoplasia , catechin , prostate cancer , prostate specific antigen , green tea , adverse effect , gastroenterology , cohort , prostate , randomized controlled trial , urology , cancer , pathology , antioxidant , polyphenol , food science , chemistry , biochemistry , alternative medicine

Several studies suggest a protective role of green tea catechins against prostate cancer (PCa). In order to evaluate the efficacy of green tea catechins for chemoprevention of PCa in patients with high-grade prostate intraepithelial neoplasia (HG-PIN) we performed a phase II clinical trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research